Incorporating AI into Commercialization Plans
Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.
In this exclusive PC Podcast interview, Steve Silvestro, president of OptimizeRx, a digital communications platform, details:
- The benefits to integrating direct-to-consumer (DTC) and healthcare provider (HCP) marketing strategies with technology, especially for patients and providers
- The application of artificial intelligence (AI) toward the pharma marketing stage of commercialization
- Ways that pharma marketers can navigate the rapidly changing landscape of state-level consumer privacy legislation
- Recommendations for pharma brands as they start to think about 2025 planning
The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.
Recent Videos
Related Content
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy Launches
October 24th 2024Article
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
